Cutaneous pigmentation in patients with chronic renal failure on maintenance hemodialysis-quantitative analysis of skin lightness and its correlation with various uremic molecules-

Accession number;06A0543051
Title;Cutaneous pigmentation in patients with chronic renal failure on maintenance hemodialysis-quantitative analysis of skin lightness and its correlation with various uremic molecules-
Author; TANIGUCHI SHINKICHI (Fac. Medicine, Wakayama Medical Univ., JPN) SHIBATA MASANORI (Koujukai Rihabiriteshonbyouin) USAMI KAZUMASA (Taigenkai Byoin)
Journal Title;Aesthetic Dermatol
Journal Code:L5200A
ISSN:1341-5530
VOL.16;NO.2;PAGE.95-101(2006)
Figure&Table&Reference;FIG.5, TBL.1, REF.14
Pub. Country;Japan
Language;Japanese
Abstract;Skin lightness was quantitatively determined in 106 patients with chronic renal failure on maintenance hemodialysis and 137 non-dialytic patients, using a spectrophotometer, CR-400 (Konica Minolta). Skin lightness was significantly reduced in hemodialytic patients (p<0.01), and correlated with the serum level of creatinine (p<0.01), although no significant relationships were observed between serum BUN and uric acid levels, and between KT/V value. Decreased skin lightness that indicated increased cutaneous pigmentation in hemodialytic patients was also correlated with serum levels of intact parathyroid hormone, .ALPHA.1- and .BETA.2-microglobulins (p<0.05, p<0.01, and p<0.05, respectively). From these results, decreased skin lightness in hemodialytic patients is thought to originate from (a) certain serum molecule (s) whose molecular weights are about 10'4'-3*10'4' biochemically, and (b) probably because about 20 % of methylguanidine, a biological metabolite from creatinine, is present as a protein-bound non-dialyzable form in the serum. (author abst.)